Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity
Data up to Jan 2025
Total Citations Per Year
Abstract
References (65)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
2000 • 2,694 citations
Humanization of an anti-p185HER2 antibody for human cancer therapy.
1992 • 1,867 citations
IgG Fc Receptors
2001 • 1,667 citations
Glycosylation and the Immune System
2001 • 1,515 citations
Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution.
1981 • 1,432 citations
Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-.ANG. resolution
1981 • 1,286 citations
Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG
1985 • 1,136 citations
High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR
2001 • 1,108 citations
The C‐type lectin superfamily in the immune system
1998 • 1,022 citations
FcγRIIIa-158V/F Polymorphism Influences the Binding of IgG by Natural Killer Cell FcγRIIIa, Independently of the FcγRIIIa-48L/R/H Phenotype
1997 • 760 citations
Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity
1999 • 751 citations
Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein
1995 • 742 citations
A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.
1997 • 698 citations
The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex
2000 • 697 citations
p185HER2 Monoclonal Antibody Has Antiproliferative Effects In Vitro and Sensitizes Human Breast Tumor Cells to Tumor Necrosis Factor
1989 • 672 citations
Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.
1989 • 519 citations
Multiple Roles for the Major Histocompatibility Complex Class I– Related Receptor FcRn
2000 • 471 citations
Humanization of an antibody directed against IgE.
1993 • 461 citations
A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding.
1991 • 460 citations
Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics
2000 • 441 citations
Biological significance of carbohydrate chains on monoclonal antibodies.
1983 • 427 citations
Refined Structure of an Intact IgG2a Monoclonal Antibody,
1997 • 424 citations
Mapping of the C1q Binding Site on Rituxan, a Chimeric Antibody with a Human IgG1 Fc
2000 • 416 citations
Crystallographic structure of an intact IgG1 monoclonal antibody 1 1Edited by I. A. Wilson
1998 • 414 citations
The IgG Fc receptor family
1998 • 398 citations
The Structure of a Human Type III Fcγ Receptor in Complex with Fc
2001 • 346 citations
IgG‐Fc‐mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation
1998 • 325 citations
Fc receptors are required in passive and active immunity to melanoma
1998 • 322 citations
Expression of GnTIII in a recombinant anti‐CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FCγRIII
2001 • 315 citations
Effect of glycosylation on antibody function: implications for genetic engineering
1997 • 311 citations
Fc RECEPTORS AND THEIR INTERACTIONS WITH IMMUNOGLOBULINS
1996 • 309 citations
Clinical trials of antibody therapy
2000 • 297 citations
Localization of the binding site for the human high-affinity Fc receptor on IgG
1988 • 287 citations
The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H
1995 • 277 citations
Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma
1997 • 249 citations
Therapeutic inhibition of the complement system.
1998 • 242 citations
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors
2000 • 190 citations
Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing FcγRI and/or FcγRII receptors
1989 • 183 citations
Recombinant human IgG molecules lacking Fcγ receptor I binding and monocyte triggering activities
1999 • 179 citations
Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions
1995 • 177 citations
Effects of galactose depletion from oligosaccharide chains on immunological activities of human IgG.
1989 • 162 citations
A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins
1990 • 158 citations
Effect of C2-Associated Carbohydrate Structure on Ig Effector Function: Studies with Chimeric Mouse-Human IgG1 Antibodies in Glycosylation Mutants of Chinese Hamster Ovary Cells
1998 • 155 citations
A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis
1998 • 153 citations
Characterization of Complex Formation by Humanized Anti-IgE Monoclonal Antibody and Monoclonal Human IgE
1995 • 146 citations
Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site‐directed mutagenesis
1994 • 117 citations
Molecular basis for a polymorphism involving Fc receptor II on human monocytes.
1989 • 110 citations
Binding characteristics of dimeric IgG subclass complexes to human neutrophils.
1989 • 108 citations
Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
1994 • 104 citations
High-Level Production of Recombinant Proteins in CHO Cells Using a Dicistronic DHFR Intron Expression Vector
1996 • 97 citations
Antibody–cytokine fusion proteins for the therapy of cancer
2001 • 81 citations
Two chinese hamster ovary glycosylation mutants affected in the conversion of GDP-mannose to GDP-fucose
1986 • 79 citations
Sialylation of Human IgG-Fc Carbohydrate by Transfected Rat α2,6-Sialyltransferase
2001 • 74 citations
Antibody-dependent cytotoxicity mediated by natural killer cells is enhanced by castanospermine-induced alterations of IgG glycosylation
1989 • 62 citations
Blood clearance in the rat of a recombinant mouse monoclonal antibody lacking the N-linked oligosaccharide side chains of the CH2 domains
1992 • 57 citations
[19] Glycosidase inhibitors in study of glycoconjugates
1994 • 49 citations
The Immunoglobulin Receptors and their Physiological and Pathological Roles in Immunity
1998 • 41 citations
The glycosylation pattern of humanized IgGI antibody (D1.3) expressed in CHO cells.
1997 • 40 citations
Introduction: bispecific antibodies
2001 • 34 citations
Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variant
1992 • 31 citations
Interaction of aglycosyl immunoglobulins with the IgG Fc transport receptor from neonatal rat gut: Comparison of deglycosylation by tunicamycin treatment and genetic engineering
1992 • 30 citations
Simple Differentiation between Core-Fucosylated and Nonfucosylated Glycans by Capillary Electrophoresis
1996 • 28 citations
On the interaction between agalactosyl IgG and Fcγ receptors
1996 • 27 citations
Role of processing of N-linked oligosaccharides in control of immunoglobulin secretion from rat hybridomas
1987 • 7 citations
Simultaneous inhibition of multiple steps in the processing of N-linked oligosaccharides does not impair immunoglobulin secretion from rat hybridoma cells.
1988 • 5 citations